HRTS vs. CNCR

Last updated Jun 4, 2026

HRTS (Tema Obesity & Cardiometabolic ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. HRTS is actively managed, while CNCR is passively managed. HRTS charges 0.75%/yr vs 0.79%/yr for CNCR.

Performance

HRTS vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HRTS

• 1D: 0.51%
• 1M: -0.90%
• YTD: -5.70%
• 6M: -5.48%
• 1Y: 20.97%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HRTS vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
HRTS Tema Obesity & Cardiometabolic ETF	-6.66%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

HRTS vs. CNCR - Sectors Allocation Comparison

Sectors	HRTS	CNCR
Healthcare	100.0%	96.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

HRTS vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS

HRTS Risk / Return Rank: 36
HRTS Sharpe Ratio Rank: 37
HRTS Sortino Ratio Rank: 38
HRTS Omega Ratio Rank: 33
HRTS Calmar Ratio Rank: 39
HRTS Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRTS vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HRTS	CNCR	Difference
Sharpe ratio Return per unit of total volatility	1.31	—	—
Sortino ratio Return per unit of downside risk	1.99	—	—
Omega ratio Gain probability vs. loss probability	1.23	—	—
Calmar ratio Return relative to maximum drawdown	1.91	—	—
Martin ratio Return relative to average drawdown	4.83	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	HRTS	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.31	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	—	—

Drawdowns

HRTS vs. CNCR - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HRTS and CNCR.

Drawdown Indicators

	HRTS	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-25.81%	0.00%	-25.81%
Max Drawdown (1Y) Largest decline over 1 year	-11.01%	—	—
Current Drawdown Current decline from peak	-9.14%	0.00%	-9.14%
Average Drawdown Average peak-to-trough decline	-9.02%	0.00%	-9.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.36%	—	—

Volatility

Volatility by Period

	HRTS	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.44%	—	—
Volatility (6M) Calculated over the trailing 6-month period	11.26%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	16.03%	0.00%	+16.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.07%	0.00%	+19.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.07%	0.00%	+19.07%

HRTS vs. CNCR - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

HRTS vs. CNCR - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.42%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%
HRTS Tema Obesity & Cardiometabolic ETF	1.42%	1.34%	1.63%

Frequently Asked Questions

Which ETF is better, HRTS or CNCR?

On fees, HRTS is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, HRTS or CNCR?

HRTS is cheaper with a 0.75% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, HRTS or CNCR?

HRTS has the higher dividend yield at 1.42%, compared with 0.00% for CNCR.

What is the main difference between HRTS and CNCR?

They also come from different issuers: Tema and Exchange Traded Concepts. Their fees differ too: 0.75% for HRTS and 0.79% for CNCR.